New York, New York (PRWEB) March 03, 2013
Zoloft lawsuits continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. According to a Pretrial Order issued on February 25th, the Zoloft litigation’s first trial is tentatively scheduled to begin on October 13, 2014. The next Status Conference in the litigation has been scheduled for April 2, 2013 (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation - MDL 2342)
“Bellwether trials will provide valuable insight into how juries might weigh claims in similar Zoloft lawsuits. We are pleased with the progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.
Zoloft Birth Defect Lawsuits
Zoloft is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. In November 2006, the FDA added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other SSRI antidepressants when taken after the 20th week of pregnancy.* In September 2009, a study published in the British Medical Journal found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester.**
Court documents indicate that at least 250 Zoloft lawsuits are pending in the Eastern District of Pennsylvania. All of the lawsuits allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spin
Copyright©2012 Vocus, Inc.
All rights reserved